CTOs on the Move

SL Pharma Labs

www.slpharmalabs.com

 
SL Pharma Labs is a Wilmington, DE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

Far West Technology Inc

Far West Technology Inc is a Goleta, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MAWD Pathology

MAWD Pathology is a Kansas City, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Swede-O

Swede-O, Inc. is a North Branch, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Allevex

Allevex is a San Jose, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Henry Scheinh

Henry Schein, Inc. is the world`s largest provider of health care products and services to office-based dental, animal health and medical practitioners. The Company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. A Fortune 500® Company and a member of the S&P 500® and NASDAQ 100® Indexes, Henry Schein employs more than 21,000 Team Schein Members and serves more than one million customers. The Company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items. The Company also offers its customers exclusive, innovative technology solutions, including practice management software and e-commerce solutions, as well as a broad range of financial services. Headquartered in Melville, N.Y., Henry Schein has operations or affiliates in 32 countries. The Company`s sales reached a record $11.6 billion in 2016, and have grown at a compound annual rate of approximately 15 percent since Henry Schein became a public company in 1995